Skye Bioscience (SKYE) Stock Price, Quote, News & History | Benzinga

SPY778.70+0.02%QQQ751.36+0.01%BTC/USD82,546.32+1.04%DIA516.42+0.06%GLD384.38−0.05%TLT77.97−0.01%

Skye Bioscience Inc (SKYE) Stock Price, Quote, News & History

SKYENASDAQ

Trade with Public

Trade with Public

$1.69

0.010.6%

Last update: Oct 8, 7:43 PM

$1.70

0.021.19%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.69

Close

$1.69

Volume / Avg.

18.67K / 87.01K

Day Range

$1.67 - $1.77

52 Wk Range

1.50 - 14.51

Market Cap

$7.53M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

3.7%

Days to Cover

1.36

Recent Skye Bioscience, Inc. News

Skye Bioscience (SKYE) Shares Rise 6% After Hours: Here's What's Driving The Move

Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.

Tanya Rawat

Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include Generation Income Properties, Barfresh Food Group, iTonic Holdings, Akanda Corp, and Reservoir Media.

Avi Kapoor

Why Domo Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Domo Inc (DOMO) stock jumped 48.8% in pre-market trading after beating Q4 earnings expectations by 117.65% and reporting a rise in revenue.

Avi Kapoor

Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year

Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower weight regain and no serious safety issues.

Vandana Singh

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-38.81M

Investing Cash Flow (TTM)

23.20M

Financing Cash Flow (TTM)

-161.13K

Free Cash Flow (TTM)

-38.81M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-15.77M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$2.50M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-613.91%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.11

Company Debt

Total Debt

$143.05K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$8.07M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-